"cell-addictive dual-target traceable nanodrug for parkinson's
accurate control of dual-receptor-engineered t cell activity
accurate control of dual-receptor-engineered t cell activity
after dual restriction and dual inhibition cells were
dual effects of the nrf2 inhibitor for inhibition of hepatitis c